In cit-bioinfo/BLCAsubtyping: Predicting bladder cancer molecular subtypes for different classification systems based on expression profiles

Overview

This package presents a tool to classify bladder tumours according to six published molecular classifications : Baylor[1], UNC[2], MDA[3], Lund[4], CIT-Curie[5], TCGA[6]

Citation

For now, you can cite the following bioRxiv preprint: bioRxiv 488460; doi: https://doi.org/10.1101/488460 https://github.com/cit-bioinfo/BLCAsubtyping

Install

You may install this package with devtools:

require(devtools)
devtools::install_github("cit-bioinfo/BLCAsubtyping")

Usage

This package provides a main function named classify which labels a batch of RNA transcriptomic profiles according to one or several of the 6 classifications implemented. classify requires the following main arguments :
- expMat : A data.frame or matrix of normalized expression data with genes in row and samples in column. RNA-seq data should be log-transformed. - gpl : A data.frame with gene/probeset annotation with at least one column with HGNC gene symbols and row names corresponding to the row names of expMat.
- symbol : A character specifying the column name of gpl containing HGNC gene symbols.
- classification.systems : A character vector with the names of the classifications to be run on the expMat data, among "Baylor"([1]), "UNC"([2]), "MDA"([3]), "Lund"([4]), "CIT"([5]), "TCGA"([6]).

Example

The package includes an example dataset [5] to illustrate the use of the main function.

library(BLCAsubtyping)
data(cit) 

cit contains the CIT dataset composed of a list with two items: 'expMat' and 'gpl'

In the following call to classify, the samples will be classified according to all 6 classification systems.

cl <- classify(expMat = cit$expMat, gpl = cit$gpl, symbol = "Symbol", classification.systems = c("Baylor", "UNC", "MDA", "CIT", "Lund", "TCGA"))

The function returns a dataframe with subtyping results from each classification system for all samples.

head(cl)

kableExtra::kable_styling(knitr::kable(head(cl), digits = 3, format = "html"))

References

[1] Mo, Q. et al. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas. J. Natl. Cancer Inst. (2018).

[2] Damrauer, J. S. et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl. Acad. Sci. U.S.A. 111, 3110–3115 (2014).

[3] Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152–165 (2014).

[4] Marzouka, N. et al. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Scientific Reports 8, 3737 (2018).

[5] Rebouissou, S. et al. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype. Sci Transl Med 6, 244ra91 (2014).

[6] Robertson, A. G. et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171, 540-556.e25 (2017).

cit-bioinfo/BLCAsubtyping documentation built on Dec. 31, 2022, 2:22 p.m.